![]() |
Trials |
A Phase II, Randomised, Double-blind, Placebo-controlled, Multi-centre Study to Assess the Efficacy and Safety of AZD8931 In Combination with Anastrozole, Compared to An-astrozole alone, in Post menopausal Women With Hormone Receptor positive, Endocrine TCancer type: Breast cancer Phase: II Principal Investigator: Bono Petri Country: FI Keywords: Finland Status: Inclusion completed Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01151215?term=mint&rank=3 |